Target intelligence / Profile preview

Mucin glycoproteins and airway secretions (MUC)

Target
MUC
Molecular classification
Glycoprotein, Secreted protein, Gel-forming mucin
01

Overview

Mucin glycoproteins are high-molecular-weight, heavily glycosylated proteins that serve as the primary structural components of airway mucus. In the human respiratory tract, the gel-forming mucins MUC5AC and MUC5B are the most critical for forming the viscoelastic gel that traps inhaled particulates and pathogens for removal via mucociliary clearance (Fahy and Dickey, NEJM, 2010). Airway secretions also contain water, electrolytes, and defensive proteins, but in disease states, they can become pathologically thickened by the accumulation of extracellular DNA and filamentous actin from degraded neutrophils. This hyperviscosity leads to airway obstruction and recurrent infections in conditions like cystic fibrosis and COPD. Therapeutic strategies target these secretions by breaking down the mucin disulfide bonds, degrading DNA polymers, or hydrating the airway surface to facilitate clearance and improve pulmonary function (StatPearls, Mucolytic Agents, 2023).

Other names
Airway mucusTracheobronchial secretionsMUC5ACMUC5BRespiratory mucusBronchial secretions
02

Mechanism of action

Reduction of disulfide bridges in mucin polymers, enzymatic hydrolysis of extracellular DNA, osmotic hydration of the airway surface liquid, and stimulation of respiratory tract fluid secretion.

03

Biological functions

Mucociliary clearancePhysical barrier formationPathogen trapping and neutralizationHydration of airway surface liquidInnate immune defense
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaBronchiectasisChronic bronchitis
05

Safety considerations

Drug-induced bronchospasmAirway irritationExcessive secretions leading to aspiration riskUnpleasant odor (sulfhydryl groups)Incompatibility with certain antibiotics in nebulized form
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

Sputum MUC5AC/MUC5B ratioMucus viscoelasticity (G' and G")Sputum DNA concentrationMucus solids content percentageForced Expiratory Volume in 1 second (FEV1)

Beyond the preview

Go deeper on Mucin glycoproteins and airway secretions (MUC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin glycoproteins and airway secretions (MUC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call